Literature DB >> 2285288

Therapy of pulmonary nocardiosis in immunocompromised mice.

M E Gombert1, L B Berkowitz, T M Aulicino, L duBouchet.   

Abstract

We compared the bactericidal efficacies of various antimicrobial agents and combinations thereof in experimentally induced Nocardia asteroides pneumonia in immunocompromised mice. Cortisone acetate treatment, which produced impaired cell-mediated immune function, was followed by nasal inoculation of 5 x 10(4) CFU of N. asteroides into each mouse. Therapy was begun 24 h after inoculation and continued for the next 96 h. Dosages of antimicrobial agents resulted in concentrations approximating levels in human serum. Animals from each of nine treatment groups were sacrificed every 24 h. The pulmonary tissue obtained was homogenized and quantitatively cultured. Results were calculated to indicate the number of CFU per gram of lung tissue. Amikacin and imipenem were the two most effective single agents studied. Sulfadiazine and ciprofloxacin were ineffective, and ceftriaxone reduced bacterial counts modestly. Combination therapy did not enhance the bactericidal activities of the agents tested. We conclude that amikacin and imipenem, as well as select broad-spectrum cephalosporins, represent therapy superior to the sulfonamides in this experimental model and may represent alternative treatment for patients who cannot tolerate sulfa agents (e.g., human immunodeficiency virus-infected patients) or who fail primary treatment.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2285288      PMCID: PMC171920          DOI: 10.1128/AAC.34.9.1766

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  13 in total

1.  Antimicrobial susceptibility patterns of Nocardia asteroides.

Authors:  R J Wallace; L C Steele; G Sumter; J M Smith
Journal:  Antimicrob Agents Chemother       Date:  1988-12       Impact factor: 5.191

2.  Factors affecting survival in nocardiosis.

Authors:  C A Presant; P H Wiernik; A A Serpick
Journal:  Am Rev Respir Dis       Date:  1973-12

3.  Nocardial cerebral abscess in the acquired immunodeficiency syndrome.

Authors:  J C Adair; A C Beck; R I Apfelbaum; J R Baringer
Journal:  Arch Neurol       Date:  1987-05

4.  Pulmonary nocardiosis in the acquired immunodeficiency syndrome. Diagnosis with bronchoalveolar lavage and treatment with non-sulphur containing drugs.

Authors:  J L Rodriguez; J L Barrio; A E Pitchenik
Journal:  Chest       Date:  1986-12       Impact factor: 9.410

5.  Virulence of Nocardia asteroides during its growth cycle.

Authors:  B L Beaman; S Maslan
Journal:  Infect Immun       Date:  1978-04       Impact factor: 3.441

6.  Treatment of experimental nocardiosis in mice: comparison of amikacin and sulfonamide.

Authors:  R J Wallace; E J Septimus; D M Musher; M B Berger; R R Martin
Journal:  J Infect Dis       Date:  1979-08       Impact factor: 5.226

7.  Contribution of neutrophils and cell-mediated immunity to control of Nocardia asteroides in murine lungs.

Authors:  G A Filice; D E Niewoehner
Journal:  J Infect Dis       Date:  1987-07       Impact factor: 5.226

8.  Susceptibility of Nocardia asteroides to various antibiotics, including newer beta-lactams, trimethoprim-sulfamethoxazole, amikacin, and N-formimidoyl thienamycin.

Authors:  M E Gombert
Journal:  Antimicrob Agents Chemother       Date:  1982-06       Impact factor: 5.191

9.  Trimethoprim-sulfamethoxazole therapy for Nocardia infections.

Authors:  R A Smego; M B Moeller; H A Gallis
Journal:  Arch Intern Med       Date:  1983-04

10.  Actinomycetales infection in the acquired immunodeficiency syndrome.

Authors:  H A Holtz; D P Lavery; R Kapila
Journal:  Ann Intern Med       Date:  1985-02       Impact factor: 25.391

View more
  11 in total

1.  Biochemical-genetic analysis and distribution of FAR-1, a class A beta-lactamase from Nocardia farcinica.

Authors:  F Laurent; L Poirel; T Naas; E B Chaibi; R Labia; P Boiron; P Nordmann
Journal:  Antimicrob Agents Chemother       Date:  1999-07       Impact factor: 5.191

2.  Efficacy of short-course ceftriaxone therapy for Borrelia burgdorferi infection in C3H mice.

Authors:  Charles Pavia; Mario A Inchiosa; Gary P Wormser
Journal:  Antimicrob Agents Chemother       Date:  2002-01       Impact factor: 5.191

3.  Pneumonia involving Aspergillus and Rhizopus spp. after a near-drowning incident with subsequent Nocardia cyriacigeorgici and N. farcinica coinfection as a late complication.

Authors:  A P van Dam; M T C Pruijm; B I J Harinck; L B S Gelinck; E J Kuijper
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-01       Impact factor: 3.267

Review 4.  Nocardiosis: updates and clinical overview.

Authors:  John W Wilson
Journal:  Mayo Clin Proc       Date:  2012-04       Impact factor: 7.616

5.  Molecular and biochemical analysis of AST-1, a class A beta-lactamase from Nocardia asteroides sensu stricto.

Authors:  L Poirel; F Laurent; T Naas; R Labia; P Boiron; P Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2001-03       Impact factor: 5.191

Review 6.  Clinical and laboratory features of the Nocardia spp. based on current molecular taxonomy.

Authors:  Barbara A Brown-Elliott; June M Brown; Patricia S Conville; Richard J Wallace
Journal:  Clin Microbiol Rev       Date:  2006-04       Impact factor: 26.132

7.  Secular trends of nocardia infection over 15 years in a tertiary care hospital.

Authors:  R Matulionyte; P Rohner; I Uçkay; D Lew; J Garbino
Journal:  J Clin Pathol       Date:  2004-08       Impact factor: 3.411

Review 8.  The medically important aerobic actinomycetes: epidemiology and microbiology.

Authors:  M M McNeil; J M Brown
Journal:  Clin Microbiol Rev       Date:  1994-07       Impact factor: 26.132

9.  Successful treatment of concomitant pulmonary nocardiosis and aspergillosis in an immunocompromised renal patient.

Authors:  R I Holt; J T Kwan; A M Sefton; J Cunningham
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-02       Impact factor: 3.267

Review 10.  Nocardiosis in transplant recipients.

Authors:  D Lebeaux; E Morelon; F Suarez; F Lanternier; A Scemla; P Frange; J-L Mainardi; M Lecuit; O Lortholary
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-11-23       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.